Avalo Therapeutics, Inc. (AVTX)
NASDAQ: AVTX · Real-Time Price · USD
14.22
+0.74 (5.49%)
At close: Oct 8, 2025, 4:00 PM EDT
14.11
-0.11 (-0.77%)
After-hours: Oct 8, 2025, 5:51 PM EDT

Avalo Therapeutics Stock Forecast

Stock Price Forecast

The 7 analysts that cover Avalo Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $30.14, which forecasts a 111.95% increase in the stock price over the next year. The lowest target is $15 and the highest is $48.

Price Target: $30.14 (+111.95%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$15$30.14$25$48
Change+5.49%+111.95%+75.81%+237.55%

Analyst Ratings

The average analyst rating for Avalo Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingApr '25May '25Jun '25Jul '25Aug '25Sep '25
Strong Buy445556
Buy221122
Hold111111
Sell000000
Strong Sell000000
Total777789

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
BTIG
BTIG
Strong Buy
Reiterates
$40
Strong BuyReiterates$40+181.29%Sep 29, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$15$25
Strong BuyMaintains$15$25+75.81%Sep 17, 2025
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Initiates
n/a
BuyInitiatesn/an/aAug 15, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Initiates
$15
Strong BuyInitiates$15+5.49%Jun 2, 2025
Jefferies
Jefferies
Strong Buy
Initiates
$23
Strong BuyInitiates$23+61.74%Mar 25, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
from 441.00K
Revenue Next Year
n/a
EPS This Year
-6.00
from -20.91
EPS Next Year
-5.69
from -6.00
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
6.70M5.40M18.05M1.92M441.00K--
Revenue Growth
-0.76%-19.42%234.40%-89.34%-77.08%--
EPS
-2,489.12-2,331.41-1,062.65-113.58-20.91-6.00-5.69
EPS Growth
-------
Forward PE
-------
No. Analysts
-----1111
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
Highn/an/a
Avgn/an/a
Lown/an/a

Revenue Growth

Revenue Growth20252026202720282029
High--
Avg--
Low--

EPS Forecast

EPS20252026202720282029
High-1.47-1.94
Avg-6.00-5.69
Low-7.01-7.53

EPS Growth

EPS Growth20252026202720282029
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.